About this trial
STRATUS-PCI is a pilot clinical trial that compares two ways of running a small heart pump called Impella CP during a high-risk procedure to open blocked heart arteries (percutaneous coronary intervention, or PCI) in patients with weakened heart muscle. The pump is placed temporarily through an artery in the leg and sits across the aortic valve to help maintain blood flow during the procedure.
Fifty patients will be randomly assigned in equal numbers to one of two pump settings: an automatic mode that adjusts flow up to higher levels as needed, or a fixed lower-flow mode (P-2). The doctor performing the heart procedure will not know which setting is being used (double-blind). A separate doctor monitors blood pressure and is allowed to change the pump setting at any time if the patient becomes unstable.
The main question is whether the automatic mode helps doctors complete the planned heart procedure more successfully and without drops in blood pressure or other complications. Results will help design a larger future trial.
Eligibility criteria
Qualifiers
signed written informed consent
age ≥ 18 years
presentation in chronic coronary syndrome or acute coronary syndrome (STEMI ≥ 24h)
Disqualifiers
no written informed consent
pregnancy
acute infection
recent ST-elevation myocardial infarction (< 24 hours) or not normalized CK-MB enzymes
Trial design
Treatments tested in this trial
- Impella CP
Treatment groups
Sponsors and collaborators
Rayyan Hemetsberger
Lead sponsor
Medical University of Vienna
Sponsor institution